Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Valeo Pharma Inc T.VPH

Alternate Symbol(s):  VPHIF | T.VPH.DB

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

TSX:VPH - Post Discussion

Valeo Pharma Inc > Webinar w $VPH CEO Steve Saviuk - Tue Sep 20 @ 1:30PM ET
View:
Post by bmreed on Sep 16, 2022 1:01pm

Webinar w $VPH CEO Steve Saviuk - Tue Sep 20 @ 1:30PM ET

Webinar - Valeo Pharma $VPH w/ CEO Steve Saviuk

Tue, September 20 at 1:30pm ET / 10:30am PT

Q&A with Radius Research 

Register Here - https://us02web.zoom.us/webinar/register/3116633432306/WN_KjRfU1TUSFWWf_py6hGnvA

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities